Glucagon-like peptide-1 receptor agonist use and renal impairment: a retrospective analysis of an electronic health records database in the U.S
The Ozempic lawsuits focus on claims that manufacturers failed to adequately warn about the risk of delayed gastric emptying and long-term digestive complications associated with the drug
The headline finding: total lean mass declined by 10.9% over that period
It found that semaglutide: Lowered the risk of major kidney problems by 24%5 Slowed down the progression of kidney disease Reduced the risk of heart issues by 18% Decreased the overall risk of death by 20% Real-World Results Studies of people using these medications in everyday life have also shown promising results: In Scandinavia, people using GLP-1 agonists had a 24% lower risk of serious kidney problems compared to those using other diabetes medications
GLP-1 Vision Side Effects: If they notice patterns of negative events, especially serious complications like vision loss, they will review whether the existing product labeling effectively communicates these risks to healthcare providers and patients
12 Hydration Station: Water is Your Weight Loss Wingman Adequate hydration is always important, but it takes on extra significance when using GLP-1 medications
